Resist have insulin inflammation may last danger of atherosclerosis function.. 's treatment

Resist have insulin inflammation may last danger of atherosclerosis function.. 's treatment
(Reuter's medical news) According to Buffalo the New York State University (SUNY) Research report,it is change to lasting the dangers of atherosclerosis not to last medium insulin.
Past research has already verified insulin resists relating to the fact that atherosclerosis had taken shape, medicine song dose which increases the sensitiveness to insulin lists ketone (troglitazone) Resist inflammation function. In research this, researcher of SUNY to insulinogenic to have, resist inflammation function, go on research by itself.
Dr. Paresh Dandona and his colleague give 10 solutions that fat experimenter's intravenous inner injection without diabetes contains insulin and not includes insulin, adopt experimenters' blood specimen to analyze with injecting before the injection for back 2, 4, 6 hours respectively, have assumption against inflammation function in order to examine insulin.
Researchers find insulin can reduce nuclear factor kappa-B (NF kappa-B) which urges inflammation Synthetic amount,if you can't increase NF kappa-B, inhibit synthetic in that factor. In addition, insulin also reduces the production of active oxygen composition through the monocyte, lead to the fact the levels of other several inflammation mediums are reduced.
Dr. Dandona points out, should find that has announced the brand-new characteristic of insulin. Since atherosclerosis is the result that blood vessel wall inflammation reacts, believe that there will be function against atherosclerosis to verify the Langerhans' islits finally.
He adds, this experiment will make such a suggestion for doctors at least: As applicable to adapt to solicit, insulin of having, the doctors should not refuse to use insulin for a patient because of worrying about insulin and increasing the danger of heart attack.
|